Atopic Dermatitis

Eli Lilly reported lebrikizumab was safe and efficacious in improving moderate to severe atopic dermatitis in combination with topical corticosteroids in the company’s third phase 3 ADhere trial, according to a company press release.

Patients taking dupilumab for atopic dermatitis experienced less severe COVID-19 symptoms than patients who used different or no treatment, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Phenotype characterization and risk factors for atopic dermatitis can help patients with prevention and therapy, according to a study.

Treatment with asivatrep provided significant and sustained relief of atopic dermatitis symptoms, including pruritus, in both adolescents and adults, according to data published in The Journal of Allergy and Clinical Immunology.

Doctors can use shared decision-making to improve outcomes for patients with atopic dermatitis, said ACAAI executive medical director Michael S. Blaiss, MD, FACAAI, during a presentation at the organization’s Annual Scientific Meeting.

Atopic dermatitis is more prevalent among individuals of color and presents in this population with unique morphologies, according to a speaker at American College of Asthma, Allergy & Immunology Annual Scientific Meeting.

Atopic dermatitis often causes psychosocial burdens that need to be addressed and managed with effective treatments, according to a literature review.

Mark Corbett, MD, an allergist with Family Allergy & Asthma in Louisville, Kentucky, will be installed as president of the American College of Allergy, Asthma & Immunology during its annual meeting scheduled for Nov. 4 to 8 in New Orleans.

The National Eczema Association has dedicated October to raising eczema awareness, with 2021 focused on the varied disease experiences among those living with and caring for this condition.

Tralokinumab significantly improved atopic dermatitis in adolescents, according to phase 3 trial results presented at the 2021 Fall Clinical Dermatology Conference.